In Vitro Characterization of CYP3A4 Inhibition and Induction of Nevirapine Analogs as Substitutes in HIV Treatment

被引:0
|
作者
Gracey, Emily G. [1 ]
Kandel, Sylvie E. [1 ]
Lampe, Jed N. [1 ]
机构
[1] Univ Colorado, Skaggs Sch Pharm, Boulder, CO 80309 USA
关键词
D O I
10.1124/jpet.122.213540
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
379
引用
收藏
页数:2
相关论文
共 50 条
  • [1] In vitro Characterization of Efficacy and Toxicity of Nevirapine Analogs as Substitutes in HIV Treatment
    Hicks, Emily
    Kandel, Sylvie
    Lampe, Jed
    FASEB JOURNAL, 2021, 35
  • [2] Inhibition of CYP3A4 expression level in vitro by fluconazole
    Wang, Kuo-An
    Huang, Jin-Ding
    DRUG METABOLISM REVIEWS, 2011, 43 : 41 - 41
  • [3] A combined model for predicting CYP3A4 clinical net drug-drug interaction based on CYP3A4 inhibition, inactivation, and induction determined in vitro
    Fahmi, Odette A.
    Maurer, Tristan S.
    Kish, Mary
    Cardenas, Edwin
    Boldt, Sherri
    Nettleton, David
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (08) : 1698 - 1708
  • [4] The Effects of CYP3A4 Induction and Inhibition on the Pharmacokinetics of Alisporivir in Humans
    Barve, Avantika
    Kovacs, Steven J.
    Ke, June
    Crabbe, Rafael
    Grosgurin, Peter
    Menetrey, Annick
    Nicolas-Metral, Valerie
    Dabovic, Kristina
    Dole, Kiran
    Zhang, Jie
    Praestgaard, Jens
    Sunkara, Gangadhar
    Stein, Daniel
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (01): : 25 - 32
  • [5] In vitro evaluation for induction of traditional Chinese medicines on CYP3A4
    Yu, Chunna
    Zeng, Su
    Chen, Shuqing
    DRUG METABOLISM REVIEWS, 2006, 38 : 138 - 138
  • [6] Modeling, Prediction, and in Vitro in Vivo Correlation of CYP3A4 Induction
    Shou, Magang
    Hayashi, Mike
    Pan, Yvonne
    Xu, Yang
    Morrissey, Kari
    Xu, Lilly
    Skiles, Gary L.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (11) : 2355 - 2370
  • [7] IN VITRO CYP3A4 INHIBITION BY FRACTIONATED RHODIOLA ROSEA EXTRACTS
    Bjorneboe, Lars H.
    Nilsen, Odd Georg
    Hellum, Bent H.
    DRUG METABOLISM REVIEWS, 2014, 45 : 156 - 156
  • [8] Characterization of the CYP3A4 Enzyme Inhibition Potential of Selected Flavonoids
    Kondza, Martin
    Bojic, Mirza
    Tomic, Ivona
    Males, Zeljan
    Rezic, Valentina
    Cavar, Ivan
    MOLECULES, 2021, 26 (10):
  • [9] Influence of CYP3A4 Induction/Inhibition on the Pharmacokinetics of Vilazodone in Healthy Subjects
    Boinpally, Ramesh
    Gad, Nayra
    Gupta, Samir
    Periclou, Antonia
    CLINICAL THERAPEUTICS, 2014, 36 (11) : 1638 - 1649
  • [10] Characterization of Genetic Variation in CYP3A4 on the Metabolism of Cabozantinib in Vitro
    Lin, Qian-meng
    Li, Ying-hui
    Lu, Xiang-ran
    Wang, Ru
    Pang, Ni-hong
    Xu, Ren-ai
    Cai, Jian-ping
    Hu, Guo-xin
    CHEMICAL RESEARCH IN TOXICOLOGY, 2019, 32 (08) : 1583 - 1590